West Pharmaceutical Services, Inc. (NYSE:WST) Announces Quarterly Dividend of $0.22

West Pharmaceutical Services, Inc. (NYSE:WST) declared a quarterly dividend on Tuesday, July 21st. Shareholders of record on Wednesday, July 29th will be paid a dividend of 0.22 per share by the medical instruments supplier on Wednesday, August 5th. This represents a c) dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Wednesday, July 29th.

West Pharmaceutical Services has increased its dividend payment by an average of 0.1%per year over the last three years. West Pharmaceutical Services has a dividend payout ratio of 12.4% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect West Pharmaceutical Services to earn $9.52 per share next year, which means the company should continue to be able to cover its $0.88 annual dividend with an expected future payout ratio of 9.2%.

West Pharmaceutical Services Trading Up 2.0%

Shares of WST stock opened at $359.32 on Wednesday. West Pharmaceutical Services has a fifty-two week low of $211.10 and a fifty-two week high of $367.66. The company has a quick ratio of 2.04, a current ratio of 2.71 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $25.39 billion, a P/E ratio of 48.04, a P/E/G ratio of 2.85 and a beta of 1.16. The stock has a 50-day simple moving average of $334.27 and a 200 day simple moving average of $286.00.

West Pharmaceutical Services (NYSE:WST) last released its earnings results on Thursday, April 23rd. The medical instruments supplier reported $2.13 EPS for the quarter, beating the consensus estimate of $1.68 by $0.45. The business had revenue of $844.90 million during the quarter, compared to analyst estimates of $779.67 million. West Pharmaceutical Services had a net margin of 16.85% and a return on equity of 19.03%. The business’s quarterly revenue was up 21.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.45 earnings per share. West Pharmaceutical Services has set its FY 2026 guidance at 8.400-8.750 EPS and its Q2 2026 guidance at 2.050-2.120 EPS. On average, sell-side analysts expect that West Pharmaceutical Services will post 8.6 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently commented on WST shares. Weiss Ratings raised shares of West Pharmaceutical Services from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, April 27th. Wolfe Research started coverage on West Pharmaceutical Services in a research report on Monday, June 1st. They set an “outperform” rating and a $375.00 price objective for the company. Zacks Research raised West Pharmaceutical Services from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, May 13th. Evercore reiterated an “outperform” rating and issued a $410.00 target price on shares of West Pharmaceutical Services in a report on Monday, July 6th. Finally, TD Cowen reissued a “buy” rating on shares of West Pharmaceutical Services in a research report on Wednesday, July 15th. Two research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, West Pharmaceutical Services presently has a consensus rating of “Buy” and a consensus target price of $363.17.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc is a global developer and manufacturer of components, systems and services that enable the containment and delivery of injectable drugs. The company focuses on high-quality packaging and delivery solutions for the pharmaceutical and biotech industries, producing primary drug packaging components and specialized drug delivery devices used for vaccines, biologics and other injectable therapies. West is known for its elastomeric closures, seals and polymer components that maintain sterility and compatibility with sensitive drug formulations.

In addition to component manufacturing, West provides engineered delivery systems and support services across the product lifecycle.